Interview Dec 4, 2024 Spatial Transcriptomics Expertise: An Interview With Dr. Wendy Teft Wendy Teft, PhD, Vice President of Precision Medicine and Head of AcelaBio AcelaBio, Alimentiv’s state-of-the-art specialty laboratory, specializes in delivering high-quality histopathology and precision medicine… Read Now
Publication Dec 4, 2024 Meta-Analysis: Evaluating Placebo Rates Across Outcomes in Eosinophilic Oesophagitis Randomised Controlled Trials Anila Qasim, Brian Feagan, Christopher Ma, David B O’Gorman, Vipul Jairath Read Now
Article Jun 30, 2023 What is the Difference between Biostatistics and Statistics? In the life sciences field, there are two terms that often come up when describing the analysis of data; biostatistics and statistics, which are often… Read Now
News Jun 26, 2023 Alimentiv Inc. launches Alimentiv Statistics London, Ontario, Canada, June 27, 2023, Alimentiv Inc. (“Alimentiv”) today announced the launch of Alimentiv Statistics, a core Alimentiv product line focused on being the… Read Now
Article Apr 18, 2023 Pharmacokinetics vs Pharmacodynamics: Understanding their role in Drug Discovery Pharmacokinetics vs Pharmacodynamics: each play a crucial role in the drug discovery process by providing insight into how drugs work in the body and how… Read Now
Article Mar 21, 2023 A Practical Look at Sample Size Re-Estimation of the Promising Zone Design The randomized controlled clinical trial (RCT) with a fixed design has become a gold standard for evaluating drug safety and efficacy since its debut. However,… Read Now
Article Jan 20, 2023 The Ultimate Glossary of Clinical Study Design & Statistical Analysis Terms At Alimentiv, we place a high priority on educating our audience and clients about clinical statistical analysis and trial design. As such, we decided it was… Read Now
News Nov 3, 2022 Alimentiv, Summit Clinical Research Announce Collaboration to drive Non-Alcoholic Steatohepatitis (NASH) Clinical Trials London, Ontario, Canada, November 3, 2022, Alimentiv Inc. (“Alimentiv”) and Summit Clinical Research, LLC (“Summit”) today announced a strategic alliance to drive Non-Alcoholic Steatohepatitis (NASH)… Read Now
